The Latin America, Middle East and Africa Glycated Albumin Assay Market would witness market growth of 11.3% CAGR during the forecast period (2023-2030).
The market is expanding as a result of rising new beginnings. Additionally, the advantages of the glycated albumin assay over the glycated hemoglobin are projected to fuel demand and propel the market's expansion. For patients and healthcare professionals, diagnostic laboratories frequently give testing choices that are both affordable and practical. Healthcare providers can avoid the need for internal testing facilities and related costs by outsourcing glycated albumin testing to diagnostics laboratories. Patients do not need to be hospitalized or attend specialized clinics to undergo glycated albumin testing at diagnostics laboratories. Diagnostics laboratories are a desirable option because of their affordability and convenience, which has raised demand and segment growth.
Blood, bodily fluids, and organs all contain albumin. Albumin maintains cell form and is a crucial component in the body's absorption of hormones, vitamins, and some drugs. Progressively, glycated albumin has been linked to a wide range of complications of diabetes, such as chronic kidney disease, cardiovascular disease, neuropathy, and other problems that can only be detected by the limited thin stream. According to a recent study, glycated albumin is now being recognized as a causal operator rather than only an observable element.
Saudi Arabia is responsible for 60% of the Gulf Cooperation Council (GCC) nations' healthcare spending, and the Saudi Arabian government continues to prioritize this industry, according to the International Trade Administration. Its healthcare budget for 2022 is $36.6 billion. The Saudi Arabian government has a $65 billion investment plan for Vision 2030 to build out the nation's healthcare system. Additionally, it targets the privatization of 290 hospitals and 2,300 basic health facilities to raise private sector involvement from 40% to 65% by 2030. In 2018, the UAE's health spending totalled $13.7 billion (AED 50.3 billion). This comprises the seven emirates' contributions to the federal budget, and their healthcare outlays. This amount is anticipated to increase by 5.4% in 2019 to $14.4 billion (AED 53 billion).
By 2023, spending is expected to increase to $18.3 billion (AED 67.2 billion), which amounts to a 6% annual compound growth rate in local and US dollars. The projected increase in health spending over ten years to 2028 is $26 billion (AED 95.5 billion). Business Monitor International (BMI) predicts that healthcare spending will represent 3.6% of the nation's GDP by 2028, up from 3.4% in 2018. The market is projected to grow due to rising healthcare expenses.
The Brazil market dominated the LAMEA Glycated Albumin Assay Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $6,982.2 Thousands by 2030. The Argentina market is showcasing a CAGR of 11.9% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 11% during (2023 - 2030).
Based on Application, the market is segmented into Type 2 Diabetes, Type 1 Diabetes, and Prediabetes. Based on End User, the market is segmented into Hospitals & Diabetic Care Center, Diagnostic Laboratory, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Glycated Albumin Assay Market is Projected to reach USD 384.5 Million by 2030, at a CAGR of 8.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Asahi Kasei Pharma Corporation (Asahi Kasei Corporation), EKF Diagnostics Holdings plc, Weldon Biotech India Private Limited, Hzymes Biotechnology Co., Ltd., Beijing Strong Biotechnologies, Inc., Diazyme Laboratories, Inc. (General Atomics), Abbexa Limited, Biomatik Corporation, Abnova Corporation and Geno Technology, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Type 2 Diabetes
- Type 1 Diabetes
- Prediabetes
By End User
- Hospitals & Diabetic Care Center
- Diagnostic Laboratory
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Asahi Kasei Pharma Corporation (Asahi Kasei Corporation)
- EKF Diagnostics Holdings plc
- Weldon Biotech India Private Limited
- Hzymes Biotechnology Co., Ltd.
- Beijing Strong Biotechnologies, Inc.
- Diazyme Laboratories, Inc. (General Atomics)
- Abbexa Limited
- Biomatik Corporation
- Abnova Corporation
- Geno Technology, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Glycated Albumin Assay Market, by Application
1.4.2 LAMEA Glycated Albumin Assay Market, by End User
1.4.3 LAMEA Glycated Albumin Assay Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. LAMEA Glycated Albumin Assay Market by Application
4.1 LAMEA Type 2 Diabetes Market by Country
4.2 LAMEA Type 1 Diabetes Market by Country
4.3 LAMEA Prediabetes Market by Country
Chapter 5. LAMEA Glycated Albumin Assay Market by End User
5.1 LAMEA Hospitals & Diabetic Care Center Market by Country
5.2 LAMEA Diagnostic Laboratory Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Glycated Albumin Assay Market by Country
6.1 Brazil Glycated Albumin Assay Market
6.1.1 Brazil Glycated Albumin Assay Market by Application
6.1.2 Brazil Glycated Albumin Assay Market by End User
6.2 Argentina Glycated Albumin Assay Market
6.2.1 Argentina Glycated Albumin Assay Market by Application
6.2.2 Argentina Glycated Albumin Assay Market by End User
6.3 UAE Glycated Albumin Assay Market
6.3.1 UAE Glycated Albumin Assay Market by Application
6.3.2 UAE Glycated Albumin Assay Market by End User
6.4 Saudi Arabia Glycated Albumin Assay Market
6.4.1 Saudi Arabia Glycated Albumin Assay Market by Application
6.4.2 Saudi Arabia Glycated Albumin Assay Market by End User
6.5 South Africa Glycated Albumin Assay Market
6.5.1 South Africa Glycated Albumin Assay Market by Application
6.5.2 South Africa Glycated Albumin Assay Market by End User
6.6 Nigeria Glycated Albumin Assay Market
6.6.1 Nigeria Glycated Albumin Assay Market by Application
6.6.2 Nigeria Glycated Albumin Assay Market by End User
6.7 Rest of LAMEA Glycated Albumin Assay Market
6.7.1 Rest of LAMEA Glycated Albumin Assay Market by Application
6.7.2 Rest of LAMEA Glycated Albumin Assay Market by End User
Chapter 7. Company Profiles
7.1 Asahi Kasei Pharma Corporation (Asahi Kasei Corporation)
7.1.1 Company Overview
7.1.2 SWOT Analysis
7.1.3 Financial Analysis
7.1.4 Segmental and Regional Analysis
7.1.5 Research & Development Expenses
7.2 EKF Diagnostics Holdings plc
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 SWOT Analysis
7.3 Weldon Biotech India Private Limited
7.3.1 Company Overview
7.3.2 SWOT Analysis
7.4 Hzymes Biotechnology Co., Ltd.
7.4.1 Company Overview
7.5 Beijing Strong Biotechnologies, Inc.
7.5.1 Company Overview
7.5.2 SWOT Analysis
7.6 Abbexa Limited
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 Biomatik Corporation
7.7.1 Company Overview
7.7.2 SWOT Analysis
7.8 Abnova Corporation
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Geno Technology, Inc.
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Diazyme Laboratories, Inc. (General Atomics)
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
7.10.3 SWOT Analysis
TABLE 1 LAMEA Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 2 LAMEA Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 3 LAMEA Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 4 LAMEA Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 5 LAMEA Type 2 Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 6 LAMEA Type 2 Diabetes Market by Country, 2023 - 2030, USD Thousands
TABLE 7 LAMEA Type 1 Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 8 LAMEA Type 1 Diabetes Market by Country, 2023 - 2030, USD Thousands
TABLE 9 LAMEA Prediabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 10 LAMEA Prediabetes Market by Country, 2023 - 2030, USD Thousands
TABLE 11 LAMEA Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 12 LAMEA Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 13 LAMEA Hospitals & Diabetic Care Center Market by Country, 2019 - 2022, USD Thousands
TABLE 14 LAMEA Hospitals & Diabetic Care Center Market by Country, 2023 - 2030, USD Thousands
TABLE 15 LAMEA Diagnostic Laboratory Market by Country, 2019 - 2022, USD Thousands
TABLE 16 LAMEA Diagnostic Laboratory Market by Country, 2023 - 2030, USD Thousands
TABLE 17 LAMEA Others Market by Country, 2019 - 2022, USD Thousands
TABLE 18 LAMEA Others Market by Country, 2023 - 2030, USD Thousands
TABLE 19 LAMEA Glycated Albumin Assay Market by Country, 2019 - 2022, USD Thousands
TABLE 20 LAMEA Glycated Albumin Assay Market by Country, 2023 - 2030, USD Thousands
TABLE 21 Brazil Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 22 Brazil Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 23 Brazil Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 24 Brazil Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 25 Brazil Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 26 Brazil Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 27 Argentina Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 28 Argentina Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 29 Argentina Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 30 Argentina Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 31 Argentina Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 32 Argentina Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 33 UAE Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 34 UAE Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 35 UAE Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 36 UAE Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 37 UAE Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 38 UAE Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 39 Saudi Arabia Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 40 Saudi Arabia Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 41 Saudi Arabia Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 42 Saudi Arabia Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 43 Saudi Arabia Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 44 Saudi Arabia Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 45 South Africa Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 46 South Africa Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 47 South Africa Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 48 South Africa Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 49 South Africa Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 50 South Africa Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 51 Nigeria Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 52 Nigeria Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 53 Nigeria Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 54 Nigeria Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 55 Nigeria Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 56 Nigeria Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 57 Rest of LAMEA Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 58 Rest of LAMEA Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 59 Rest of LAMEA Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 60 Rest of LAMEA Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 61 Rest of LAMEA Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 62 Rest of LAMEA Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 63 Key Information – Asahi Kasei Pharma Corporation
TABLE 64 Key Information – EKF Diagnostics Holdings plc
TABLE 65 Key Information – Weldon Biotech India Private Limited
TABLE 66 Key Information – Hzymes Biotechnology Co., Ltd.
TABLE 67 Key Information – Beijing Strong Biotechnologies, Inc.
TABLE 68 Key Information – Abbexa Limited
TABLE 69 Key Information – Biomatik Corporation
TABLE 70 Key Information – Abnova Corporation
TABLE 71 Key Information – Geno Technology, Inc.
TABLE 72 Key Information – Diazyme Laboratories, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Glycated Albumin Assay Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting the Glycated Albumin Assay Market
FIG 4 Porter’s Five Forces Analysis – Glycated Albumin Assay Market
FIG 5 LAMEA Glycated Albumin Assay Market share by Application, 2022
FIG 6 LAMEA Glycated Albumin Assay Market share by Application, 2030
FIG 7 LAMEA Glycated Albumin Assay Market by Application, 2019 - 2030, USD Thousands
FIG 8 LAMEA Glycated Albumin Assay Market share by End User, 2022
FIG 9 LAMEA Glycated Albumin Assay Market share by End User, 2030
FIG 10 LAMEA Glycated Albumin Assay Market by End User, 2019 - 2030, USD Thousands
FIG 11 LAMEA Glycated Albumin Assay Market share by Country, 2022
FIG 12 LAMEA Glycated Albumin Assay Market share by Country, 2030
FIG 13 LAMEA Glycated Albumin Assay Market by Country, 2019 - 2030, USD Thousands
FIG 14 SWOT Analysis: Asahi Kasei Pharma Corporation
FIG 15 SWOT Analysis: EKF Diagnostics Holdings plc
FIG 16 SWOT Analysis: Weldon Biotech India Private Limited
FIG 17 SWOT Analysis: Beijing Strong Biotechnologies, Inc.
FIG 18 SWOT Analysis: Abbexa Limited
FIG 19 SWOT Analysis: Biomatik Corporation
FIG 20 SWOT Analysis: Abnova Corporation
FIG 21 SWOT Analysis: Geno Technology, Inc.
FIG 22 SWOT Analysis: Diazyme Laboratories, Inc.